Search Results - "Avdeev, Sergey N."

Refine Results
  1. 1

    Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study by Ignatova, Galina L., Avdeev, Sergey N., Antonov, Vladimir N.

    Published in Scientific reports (05-08-2021)
    “…Vaccination against Streptococcus pneumoniae is among the most effective measures for preventing pneumonia and reducing the rate of chronic obstructive…”
    Get full text
    Journal Article
  2. 2

    Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID‑19 associated acute respiratory distress syndrome by Avdeev, Sergey N, Nekludova, Galina V, Trushenko, Natalia V, Tsareva, Natalia A, Yaroshetskiy, Andrey I, Kosanovic, Djuro

    Published in Critical care (London, England) (25-01-2021)
    “…[...]in patients with severe COVID-19, response to PP probably depends on the extent and localization of lung tissue changes. [...]all authors were involved in…”
    Get full text
    Journal Article
  3. 3

    Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure by Yaroshetskiy, Andrey I, Avdeev, Sergey N, Krasnoshchekova, Anna P, Nuralieva, Galia S

    Published in Critical care (London, England) (25-10-2022)
    “…[...]let’s focus on the oxygenation status as a stratification tool for the selection of the appropriate respiratory support method in ARDS [8]. [...]all…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients by Budnevsky, Andrey V, Avdeev, Sergey N, Kosanovic, Djuro, Shishkina, Victoria V, Filin, Andrey A, Esaulenko, Dmitry I, Ovsyannikov, Evgeniy S, Samoylenko, Tatiana V, Redkin, Alexander N, Suvorova, Olga A, Perveeva, Inna M

    Published in Respiratory research (21-12-2022)
    “…There is still insufficient knowledge with regard to the potential involvement of mast cells (MCs) and their mediators in the pathology of coronavirus…”
    Get full text
    Journal Article
  6. 6

    High‑flow nasal cannula is not more effective than conventional oxygen therapy for acute exacerbation of COPD with mild hypercapnia: we are not sure by Avdeev, Sergey N, Yaroshetskiy, Andrey I, Nuralieva, Galia S, Avdeev, Ivan S, Shmidt, Anna E

    Published in Critical care (London, England) (31-05-2022)
    “…[...]the necessity for oxygen therapy in the enrolled patients is also questionable. According to the data presented, the initial mean values of PaO2 were…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Northern Pulmonary Hypertension: A Forgotten Kind of Pulmonary Circulation Pathology by Kosanovic, Djuro, Avdeev, Sergey N, Milovanov, Andrey P, Chernyaev, Andrey L

    Published in Life (Basel, Switzerland) (13-07-2024)
    “…Northern pulmonary hypertension (NPH) is a medical condition that is still enigmatic in non-Russian-speaking countries. The extant previous literature is…”
    Get full text
    Journal Article
  9. 9

    Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia by Nashatyreva, Maria S, Trofimenko, Irina N, Chernyak, Boris A, Avdeev, Sergey N

    Published in Life (Basel, Switzerland) (01-01-2023)
    “…Interstitial lung diseases (ILD) are part of a large heterogeneous group of diseases that differ in many ways (in their cause, clinical presentation, and…”
    Get full text
    Journal Article
  10. 10

    Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale by Kosanovic, Djuro, Yaroshetskiy, Andrey I., Tsareva, Natalia A., Merzhoeva, Zamira M., Trushenko, Natalia V., Nekludova, Galina V., Schermuly, Ralph Theo, Avdeev, Sergey N.

    “…•COVID-19 may be characterized by an abnormal coagulation process and microvascular thrombosis of the lung vasculature.•COVID-19 may also be linked with acute…”
    Get full text
    Journal Article
  11. 11

    Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally by Gredic, Marija, Karnati, Srikanth, Ruppert, Clemens, Guenther, Andreas, Avdeev, Sergey N, Kosanovic, Djuro

    Published in Cells (Basel, Switzerland) (28-04-2023)
    “…Combined pulmonary fibrosis and emphysema (CPFE) is a recently recognized syndrome that, as its name indicates, involves the existence of both interstitial…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Involvement of Mast Cells in the Pathology of COVID-19: Clinical and Laboratory Parallels by Budnevsky, Andrey V, Avdeev, Sergey N, Kosanovic, Djuro, Ovsyannikov, Evgeniy S, Savushkina, Inessa A, Alekseeva, Nadezhda G, Feigelman, Sofia N, Shishkina, Viktoria V, Filin, Andrey A, Esaulenko, Dmitry I, Perveeva, Inna M

    Published in Cells (Basel, Switzerland) (19-04-2024)
    “…Recent studies suggested the potential role of mast cells (MCs) in the pathology of coronavirus disease 2019 (COVID-19). However, the precise description of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Influence of Anxiety/Depression on the Subjective Evaluation of Cough in Patients with Chronic Obstructive Pulmonary Disease and Obesity by Ovsyannikov, Evgeniy S, Avdeev, Sergey N, Budnevsky, Andrey V, Shkatova, Yanina S

    Published in Medicina (Kaunas, Lithuania) (14-05-2019)
    “…Obesity and anxiety and/or depression are common comorbidities in patients with chronic obstructive pulmonary disease (COPD). For doctors treating COPD, cough…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: A pilot study by Avdeev, Sergey N., Trushenko, Natalia V., Tsareva, Natalia A., Yaroshetskiy, Andrey I., Merzhoeva, Zamira M., Nuralieva, Galia S., Nekludova, Galina V., Chikina, Svetlana Yu, Gneusheva, Tatiana Yu, Suvorova, Olga A., Shmidt, Anna E.

    Published in Cytokine (Philadelphia, Pa.) (01-10-2021)
    “…•Netakimab is an IL-17 antibody that neutralizes the activity of IL-17.•Netakimab was given subcutaneously at a single dose of 120 mg to 88 patients with…”
    Get full text
    Journal Article